Document Detail


The relationship between myocardial blood flow and glucose uptake in ischemic canine myocardium determined with fluorine-18-deoxyglucose.
MedLine Citation:
PMID:  1613576     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The relationship between myocardial blood flow as a marker of severity of ischemia and exogenous glucose utilization was examined following occlusion of the left anterior descending coronary artery in 10 fasted, anesthetized, open-chest dogs. Fluorine-18-fluorodeoxyglucose (FDG) was injected 10 min after the onset of ischemia and serial blood samples were obtained to measure FDG in plasma. Tracer-labeled microspheres, used to measure myocardial blood flow (MBF), were injected 10 and 40 min postocclusion. After the last microsphere injection, the heart was arrested and removed rapidly. Tissue samples of the left ventricle were obtained, weighed and FDG counts were determined. Two days later, the same samples were assayed for radioactivity from the tracer-labeled microspheres and blood flow was calculated. Thus, FDG uptake and MBF measurements were made in the same tissue samples. When normalized for variations in blood flow, there were no significant differences in FDG uptake between the subendocardial and subepicardial halves of the tissue samples. FDG uptake was relatively high and uniform in normal myocardium, paralleling the pattern of MBF. In ischemic myocardium, however, FDG uptake and MBF did not vary in parallel. In tissue samples with MBF reduced by up to 80% from control levels, relative FDG uptake increased such that absolute FDG uptake remained at normal or near normal levels. In samples with more severe ischemia, FDG uptake decreased precipitously with additional decrements in MBF. We propose that sufficient glycolytic flux may be sustained to maintain cellular viability when perfusion is above the threshold value. Below the threshold, however, irreversible changes may be initiated.
Authors:
V Kalff; M Schwaiger; N Nguyen; T B McClanahan; K P Gallagher
Related Documents :
25020796 - P412effect of post-infarction changes of heart on autoregulation of cerebral circulatio...
6094636 - Effect of beta-adrenergic blockade with timolol on myocardial blood flow during exercis...
1850596 - Reduced neuronal noradrenaline overflow in the ischaemic rat heart: importance of the s...
7460216 - The relationship between myocardial blood flow and contraction by myocardial layer in t...
21939786 - Respiratory, cerebrovascular and cardiovascular responses to isocapnic hypoxia.
17726816 - The use of levonorgestrel - iud in the treatment of uterine myoma in thai women.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of nuclear medicine : official publication, Society of Nuclear Medicine     Volume:  33     ISSN:  0161-5505     ISO Abbreviation:  J. Nucl. Med.     Publication Date:  1992 Jul 
Date Detail:
Created Date:  1992-07-28     Completed Date:  1992-07-28     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0217410     Medline TA:  J Nucl Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1346-53     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Coronary Circulation / physiology*
Coronary Disease / metabolism*,  radionuclide imaging
Deoxyglucose / analogs & derivatives*,  diagnostic use
Dogs
Fluorodeoxyglucose F18
Glucose / pharmacokinetics*
Grant Support
ID/Acronym/Agency:
HL32043/HL/NHLBI NIH HHS; R01 HL41047/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
154-17-6/Deoxyglucose; 50-99-7/Glucose; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of infectious diabetic foot complications with indium-111-labeled human nonspecific immun...
Next Document:  Interspecies variation in biodistribution of technetium (2-carbomethoxy-2-isocyanopropane)6+.